Data / Drug companies / Blue Heron Pharmaceuticals, LLC
Blue Heron Pharmaceuticals, LLC: 15 products in the FDA NDC directory, labeler code 85622
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Blue Heron Pharmaceuticals, LLC (labeler code 85622) lists 15 products in the FDA National Drug Code Directory, covering 10 finished drugs by generic name. By type: 11 over the counter drugs, 4 prescription drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on November 4, 2026.
The request: Watch Blue Heron Pharmaceuticals, LLC (FDA labeler code 85622): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 85622
- Products in commercial distribution
- 15
- Packages
- 13
- Finished drugs by generic name
- 10
- Prescription products
- 4
- Over the counter products
- 11
- Flagged as original packager
- 9 of 9 products that carry the flag
- Started marketing in the last 12 months
- 14
- Earliest marketing start
- October 13, 2025
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 7 | 46.7% |
| Other unapproved drugs | 7 | 46.7% |
| Generic drugs (ANDA) | 1 | 6.7% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 11 | 73.3% |
| Prescription drugs | 4 | 26.7% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Lidocaine 4% | 5 | 45 |
| Urea | 2 | 17 |
| Urevia 10 | 1 | 1 |
| Metaxalone | 1 | 38 |
| Urea 39 | 1 | 1 |
| Urea 40% | 1 | 1 |
| Menthol | 1 | 263 |
| Neurocool patches | 1 | 1 |
| Lidocaine | 1 | 216 |
| Camphor, menthol | 1 | 35 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Patch | 7 | 46.7% |
| Cream | 4 | 26.7% |
| Liquid | 2 | 13.3% |
| Lotion | 1 | 6.7% |
| Tablet | 1 | 6.7% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| Amide Local Anesthetic | 7 |
| Antiarrhythmic | 7 |
| Muscle Relaxant | 1 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Lidocaine 4% Patch | 85622-531 | Patch | Over the counter monograph drugs | November 4, 2026 |
| Urevia 10 | 85622-600 | Lotion | Other unapproved drugs | October 21, 2026 |
| Lidocaine 4% Patch | 85622-532 | Patch | Over the counter monograph drugs | October 21, 2026 |
| Lidocaine 4% Patch | 85622-520 | Patch | Over the counter monograph drugs | September 30, 2026 |
| Metaxalone | 85622-950 | Tablet | Generic drugs (ANDA) | September 15, 2026 |
| Lidocaine 4% Patch | 85622-522 | Patch | Over the counter monograph drugs | September 14, 2026 |
| Lidocaine 4% Patch | 85622-521 | Patch | Over the counter monograph drugs | August 11, 2026 |
| Urevia Plus | 85622-603 | Cream | Other unapproved drugs | June 4, 2026 |
| Urevia | 85622-602 | Cream | Other unapproved drugs | June 4, 2026 |
| Urevex | 85622-605 | Cream | Other unapproved drugs | April 28, 2026 |
| Neurocaine | 85622-501 | Patch | Over the counter monograph drugs | April 16, 2026 |
| NeuroFreeze | 85622-511 | Liquid | Other unapproved drugs | February 23, 2026 |
| NeuroSoothe | 85622-510 | Liquid | Other unapproved drugs | February 23, 2026 |
| Uredex | 85622-601 | Cream | Other unapproved drugs | January 7, 2026 |
| NeuroCool Patches | 85622-500 | Patch | Over the counter monograph drugs | October 13, 2025 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.